Petcu C P, Droc I
"Carol Davila" University of Medicine, Bucharest, Romania.
Chirurgia (Bucur). 2013 Mar-Apr;108(2):226-33.
The optimal management for pericardial effusions with cardiac tamponade remains controversial. This study compares the results after two commonly performed techniques: subxiphoid surgical pericardial drainage (DPSS) and percutaneous catheter drainage (DPPK).
We conducted a 5-year retrospective study to analyse the outcome after DPSS and DPPK in patients with non-traumatic pericardial effusions with cardiac tamponade.
Patients with non-traumatic cardiac tamponade were treated with DPSS (N=138) and DPPK (N=54). There were no statistical differences between groups regarding: age, drainage volume and duration of drainage. The etiology was malignant in 72 patients and benign in 120 patients. The 2-year survival was statistically non-significant: 55,1% in the surgical group and 44,4% in the percutaneous group, but there was a slight prevalence of malignant diagnosis in the first group (38% versus 35%). The 1-year survival in patients with proved cyto- hystological malignancy was statistically poorer than in patients with malignant diagnosis and with both negative cytology and hystology (7% versus 33%). The 1-year freedom of re-intervention for recurrence of pericardial effusion was statistically better in the surgical group as in the percutaneous one (92.8% versus 79,6%).
DPSS and DPPK can be both safely performed. DPSS appears to decrease intervention-necessitating recurrence, but it brings a minimal advantage for the malignant diagnosis over cytology alone.
心包积液合并心脏压塞的最佳治疗方法仍存在争议。本研究比较了两种常用技术的结果:剑突下心包手术引流(DPSS)和经皮导管引流(DPPK)。
我们进行了一项为期5年的回顾性研究,以分析DPSS和DPPK治疗非创伤性心包积液合并心脏压塞患者的结果。
非创伤性心脏压塞患者接受了DPSS(N = 138)和DPPK(N = 54)治疗。两组在年龄、引流量和引流持续时间方面无统计学差异。病因方面,72例为恶性,120例为良性。2年生存率无统计学意义:手术组为55.1%,经皮组为44.4%,但第一组恶性诊断的比例略高(38%对35%)。经细胞组织学证实为恶性的患者1年生存率在统计学上低于恶性诊断但细胞学和组织学均为阴性的患者(7%对33%)。心包积液复发再次干预的1年无复发生存率在手术组统计学上优于经皮组(92.8%对79.6%)。
DPSS和DPPK均可安全实施。DPSS似乎可降低因复发而需要再次干预的情况,但与单纯细胞学检查相比,其在恶性诊断方面优势极小。